Netherlands-based Wolters Kluwer today announced the launch of UpToDate Advanced, a mobile-friendly physician tool that offers interactive guidance through clinical decision-making. The new offering builds on medical information and images collected within the company’s longstanding clinical reference information product UpToDate, which is used by 1.5 million physicians annually, according to the company.
from MobiHealthNews http://ift.tt/2HUyyyH
March 01, 2018
Rose
MobiHealthNews
No comments
Related Posts:
BrainQ's AI-backed neurodisorder therapies collect $5.3MJerusalem, Israel-based BrainQ has raised $5.3 million in its latest funding rounding, bringing the digital neurodisorder therapy company’s total funding to $8.8 million. Participants in the round included Qure Ventures, OurC… Read More
Simulation study shows some benefits from inflight emergency care appA new simulation study of 58 physicians shows that AirRx, an iOS and Android app, can help physicians to perform better during inflight emergencies in some ways, though it might slow them down in others. from MobiHealthNews … Read More
Verily submitted patent application for smart diaper able to detect, differentiate between wasteVerily Life Sciences has filed a patent application for a “smart diaper” carrying a sensor for detecting and differentiating between feces and urine. The diaper would also contain a transmitter capable of wirelessly communica… Read More
Survey: Nine out of ten doctors worry about negative online reviewsIn a survey of 200 healthcare professionals, 80 percent rated their online reputation as very or extremely important and 90 percent expressed concern about the risks of negative feedback. But only 46 percent of responden… Read More
Otsimo expands autism education app in USEarlier this month Otsimo, a digital health startup focused on developmental disorders, rolled out an expansion of its app in the US to help kids with autism, down syndrome, and other cognitive learning disorders. from… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment